Eisai Japan To Start Providing Lymphatic Filariasis Drug From India Factory
This article was originally published in PharmAsia News
Executive Summary
Eisai has obtained pre-approval from the World Health Organization regarding the manufacture of lymphatic filariasis drug diethylcarbamazaine 100 mg at their factory in India.